864 related articles for article (PubMed ID: 31964509)
1. Molecular Mechanisms Driving mRNA Degradation by m
Lee Y; Choe J; Park OH; Kim YK
Trends Genet; 2020 Mar; 36(3):177-188. PubMed ID: 31964509
[TBL] [Abstract][Full Text] [Related]
2. Endoribonucleolytic Cleavage of m
Park OH; Ha H; Lee Y; Boo SH; Kwon DH; Song HK; Kim YK
Mol Cell; 2019 May; 74(3):494-507.e8. PubMed ID: 30930054
[TBL] [Abstract][Full Text] [Related]
3. m
Boo SH; Ha H; Kim YK
Cell Rep; 2022 Sep; 40(10):111317. PubMed ID: 36070699
[TBL] [Abstract][Full Text] [Related]
4. YTHDF2 destabilizes m(6)A-containing RNA through direct recruitment of the CCR4-NOT deadenylase complex.
Du H; Zhao Y; He J; Zhang Y; Xi H; Liu M; Ma J; Wu L
Nat Commun; 2016 Aug; 7():12626. PubMed ID: 27558897
[TBL] [Abstract][Full Text] [Related]
5. UPF1 promotes rapid degradation of m
Boo SH; Ha H; Lee Y; Shin MK; Lee S; Kim YK
Cell Rep; 2022 May; 39(8):110861. PubMed ID: 35613594
[TBL] [Abstract][Full Text] [Related]
6. N6-methyladenosine-dependent regulation of messenger RNA stability.
Wang X; Lu Z; Gomez A; Hon GC; Yue Y; Han D; Fu Y; Parisien M; Dai Q; Jia G; Ren B; Pan T; He C
Nature; 2014 Jan; 505(7481):117-20. PubMed ID: 24284625
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-145 Modulates
Yang Z; Li J; Feng G; Gao S; Wang Y; Zhang S; Liu Y; Ye L; Li Y; Zhang X
J Biol Chem; 2017 Mar; 292(9):3614-3623. PubMed ID: 28104805
[No Abstract] [Full Text] [Related]
8. YTHDF3 facilitates translation and decay of N
Shi H; Wang X; Lu Z; Zhao BS; Ma H; Hsu PJ; Liu C; He C
Cell Res; 2017 Mar; 27(3):315-328. PubMed ID: 28106072
[TBL] [Abstract][Full Text] [Related]
9. YTH Domain: A Family of N
Liao S; Sun H; Xu C
Genomics Proteomics Bioinformatics; 2018 Apr; 16(2):99-107. PubMed ID: 29715522
[TBL] [Abstract][Full Text] [Related]
10. YTHDC1 mediates nuclear export of N
Roundtree IA; Luo GZ; Zhang Z; Wang X; Zhou T; Cui Y; Sha J; Huang X; Guerrero L; Xie P; He E; Shen B; He C
Elife; 2017 Oct; 6():. PubMed ID: 28984244
[No Abstract] [Full Text] [Related]
11. YTHDF2/3 Are Required for Somatic Reprogramming through Different RNA Deadenylation Pathways.
Liu J; Gao M; Xu S; Chen Y; Wu K; Liu H; Wang J; Yang X; Wang J; Liu W; Bao X; Chen J
Cell Rep; 2020 Sep; 32(10):108120. PubMed ID: 32905781
[TBL] [Abstract][Full Text] [Related]
12. A novel protein, Pho92, has a conserved YTH domain and regulates phosphate metabolism by decreasing the mRNA stability of PHO4 in Saccharomyces cerevisiae.
Kang HJ; Jeong SJ; Kim KN; Baek IJ; Chang M; Kang CM; Park YS; Yun CW
Biochem J; 2014 Feb; 457(3):391-400. PubMed ID: 24206186
[TBL] [Abstract][Full Text] [Related]
13. N(6)-methyladenosine Modulates Messenger RNA Translation Efficiency.
Wang X; Zhao BS; Roundtree IA; Lu Z; Han D; Ma H; Weng X; Chen K; Shi H; He C
Cell; 2015 Jun; 161(6):1388-99. PubMed ID: 26046440
[TBL] [Abstract][Full Text] [Related]
14. UPF1 adds an m
Gibbs MR; Chanfreau GF
Cell Rep; 2022 May; 39(8):110898. PubMed ID: 35613576
[TBL] [Abstract][Full Text] [Related]
15. Identification of YTH Domain-Containing Proteins as the Readers for N1-Methyladenosine in RNA.
Dai X; Wang T; Gonzalez G; Wang Y
Anal Chem; 2018 Jun; 90(11):6380-6384. PubMed ID: 29791134
[TBL] [Abstract][Full Text] [Related]
16. YTHDF2 mediates the mRNA degradation of the tumor suppressors to induce AKT phosphorylation in N6-methyladenosine-dependent way in prostate cancer.
Li J; Xie H; Ying Y; Chen H; Yan H; He L; Xu M; Xu X; Liang Z; Liu B; Wang X; Zheng X; Xie L
Mol Cancer; 2020 Oct; 19(1):152. PubMed ID: 33121495
[TBL] [Abstract][Full Text] [Related]
17. Recognition of RNA N
Huang H; Weng H; Sun W; Qin X; Shi H; Wu H; Zhao BS; Mesquita A; Liu C; Yuan CL; Hu YC; Hüttelmaier S; Skibbe JR; Su R; Deng X; Dong L; Sun M; Li C; Nachtergaele S; Wang Y; Hu C; Ferchen K; Greis KD; Jiang X; Wei M; Qu L; Guan JL; He C; Yang J; Chen J
Nat Cell Biol; 2018 Mar; 20(3):285-295. PubMed ID: 29476152
[TBL] [Abstract][Full Text] [Related]
18. Decoding m
Han B; Wei S; Li F; Zhang J; Li Z; Gao X
Cancer Lett; 2021 Oct; 518():256-265. PubMed ID: 34339799
[TBL] [Abstract][Full Text] [Related]
19. METTL3/YTHDF2 m
Xie H; Li J; Ying Y; Yan H; Jin K; Ma X; He L; Xu X; Liu B; Wang X; Zheng X; Xie L
J Cell Mol Med; 2020 Apr; 24(7):4092-4104. PubMed ID: 32126149
[TBL] [Abstract][Full Text] [Related]
20. YTHDF2 reduction fuels inflammation and vascular abnormalization in hepatocellular carcinoma.
Hou J; Zhang H; Liu J; Zhao Z; Wang J; Lu Z; Hu B; Zhou J; Zhao Z; Feng M; Zhang H; Shen B; Huang X; Sun B; Smyth MJ; He C; Xia Q
Mol Cancer; 2019 Nov; 18(1):163. PubMed ID: 31735169
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
